Show simple item record

dc.contributor.authorMárquez-Expósito, Laura
dc.contributor.authorTejedor Santamaria, Lucía
dc.contributor.authorValentijn, Floris A.
dc.contributor.authorTejera-Muñoz, Antonio
dc.contributor.authorRayego-Mateos, Sandra
dc.contributor.authorMarchant, Vanessa
dc.contributor.authorRodrigues-Diez, Raul R.
dc.contributor.authorRubio-Soto, Irene
dc.contributor.authorKnoppert, Sebastiaan N.
dc.contributor.authorOrtiz Arduán, Alberto 
dc.contributor.authorRamos, Adrián M.
dc.contributor.authorGoldschmeding, Roel
dc.contributor.authorRuiz Ortega, Marta 
dc.contributor.otherUAM. Departamento de Medicinaes_ES
dc.date.accessioned2023-03-08T16:45:07Z
dc.date.available2023-03-08T16:45:07Z
dc.date.issued2022-01-31
dc.identifier.citationAntioxidants 11.2 (2022): 301en_US
dc.identifier.issn2076-3921 (online)en_US
dc.identifier.urihttp://hdl.handle.net/10486/706599
dc.description.abstractChronic kidney disease (CKD) can be considered as a clinical model for premature aging. However, non‐invasive biomarkers to detect early kidney damage and the onset of a senescent phenotype are lacking. Most of the preclinical senescence studies in aging have been done in very old mice. Furthermore, the precise characterization and over-time development of age-related senes-cence in the kidney remain unclear. To address these limitations, the age-related activation of cellular senescence-associated mechanisms and their correlation with early structural changes in the kidney were investigated in 3- to 18-month-old C57BL6 mice. Inflammatory cell infiltration was ob-served by 12 months, whereas tubular damage and collagen accumulation occurred later. Early activation of cellular-senescence-associated mechanisms was found in 12-month-old mice, character-ized by activation of the DNA-damage-response (DDR), mainly in tubular cells; activation of the antioxidant NRF2 pathway; and klotho downregulation. However, induction of tubular-cell-cycle-arrest (CCA) and overexpression of renal senescent-associated secretory phenotype (SASP) components was only found in 18-month-old mice. In aging mice, both inflammation and oxidative stress (marked by elevated lipid peroxidation and NRF2 inactivation) remained increased. These findings support the hypothesis that prolonged DDR and CCA, loss of nephroprotective factors (klotho), and dysfunctional redox regulatory mechanisms (NRF2/antioxidant defense) can be early drivers of age-related kidney-damage progressionen_US
dc.description.sponsorshipThis research was funded by grants from the Instituto de Salud Carlos III (ISCIII); Fondos FEDER European Union (PI17/00119, PI20/00140; and DTS20/00083 to M.R.-O.; PI18/01133 to A.M.R.); Sara Borrell’ program from Instituto de Salud Carlos III (ISCIII) (grant number CD20/00042 to R.R.R.-D.); Red de Investigación Renal REDINREN: RD16/0009/0003 and RICORS program to RICORS2040 496 (RD21/0005), to M.R.-O., Sociedad Española de Nefrología; “NOVELREN-CM: Enfermedad renal crónica: nuevas Estrategias para la prevención, Diagnóstico y tratamiento” (B2017/BMD3751 to M.R.-O.); “Convocatoria Dinamización Europa Investigación 2019” MINECO (EIN2019-103294 to M.R.-O.); Juan de la Cierva incorporacion grant: IJC2018-035187-I to S.R.-M.; innovation program under the Marie Skłodowska-Curie grant of the European Union’s Horizon 2020 (IMProvePD ID: 812699) to M.R.-O.; and Fundacion Conchita Rabago to L.T.-Sen_US
dc.format.extent19 pag.es_ES
dc.format.mimetypeapplication/pdfen_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.relation.ispartofAntioxidantsen_US
dc.rights© 2022 by the authorsen_US
dc.subject.otherAging kidneyen_US
dc.subject.otherCellular senescenceen_US
dc.subject.otherFibrosises_ES
dc.subject.otherInflammagingen_US
dc.subject.otherNRF2en_US
dc.subject.otherOxidationen_US
dc.titleOxidative stress and cellular senescence are involved in the aging kidneyen_US
dc.typearticleen_US
dc.subject.ecienciaMedicinaes_ES
dc.relation.publisherversionhttps://doi.org/10.3390/antiox11020301en_US
dc.identifier.doi10.3390/antiox11020301en_US
dc.identifier.publicationfirstpage301-1es_ES
dc.identifier.publicationissue2es_ES
dc.identifier.publicationlastpage301-19es_ES
dc.identifier.publicationvolume11es_ES
dc.relation.projectIDGobierno de España. PI17/00119es_ES
dc.relation.projectIDGobierno de España. PI18/01133
dc.relation.projectIDComunidad de Madrid. B2017/BMD3751
dc.relation.projectIDGobierno de España. EIN2019-103294
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/812699/EU//MSC
dc.type.versioninfo:eu-repo/semantics/publishedVersionen_US
dc.rights.ccReconocimientoes_ES
dc.rights.accessRightsopenAccessen_US
dc.facultadUAMFacultad de Medicinaes_ES
dc.institutoUAMInstituto de Investigación Sanitaria Fundación Jiménez Díaz (ISS-FJD)es_ES


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record